{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:45:34Z","timestamp":1760013934985},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,5,17]],"date-time":"2015-05-17T00:00:00Z","timestamp":1431820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12020-015-0619-5","type":"journal-article","created":{"date-parts":[[2015,5,16]],"date-time":"2015-05-16T11:18:15Z","timestamp":1431775095000},"page":"524-533","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center"],"prefix":"10.1007","volume":"51","author":[{"given":"Susanna","family":"Bacigaluppi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Anania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola Luigi","family":"Bragazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Criminelli","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Benvegnu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Nazzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Spaziante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Ferone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Zona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,17]]},"reference":[{"issue":"1","key":"619_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1009965803750","volume":"2","author":"IM Holdaway","year":"1999","unstructured":"I.M. Holdaway, C. Rajasoorya, Epidemiology of acromegaly. Pituitary 2(1), 29\u201341 (1999)","journal-title":"Pituitary"},{"issue":"1","key":"619_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","volume":"12","author":"L Alexander","year":"1980","unstructured":"L. Alexander, D. Appleton, R. Hall, W.M. Ross, R. Wilkinson, Epidemiology of acromegaly in the Newcastle region. Clin. Endocrinol. (Oxf.) 12(1), 71\u201379 (1980)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"619_CR3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","volume":"223","author":"BA Bengtsson","year":"1988","unstructured":"B.A. Bengtsson, S. Eden, I. Ernest, A. Oden, B. Sjogren, Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta. Med. Scand. 223(4), 327\u2013335 (1988)","journal-title":"Acta. Med. Scand."},{"issue":"4","key":"619_CR4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-07-0358","volume":"157","author":"M Bex","year":"2007","unstructured":"M. Bex, R. Abs, G. T\u2019Sjoen, J. Mockel, B. Velkeniers, K. Muermans, D. Maiter, AcroBel\u2013the Belgian registry on acromegaly: a survey of the \u2018real-life\u2019 outcome in 418 acromegalic subjects. Eur. J. Endocrinol. 157(4), 399\u2013409 (2007). doi: 10.1530\/EJE-07-0358","journal-title":"Eur. J. Endocrinol."},{"issue":"11 Suppl Intern","key":"619_CR5","first-page":"67","volume":"28","author":"AF Daly","year":"2005","unstructured":"A.F. Daly, P. Petrossians, A. Beckers, An overview of the epidemiology and genetics of acromegaly. J. Endocrinol. Invest. 28(11 Suppl International), 67\u201369 (2005)","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"619_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03344942","volume":"16","author":"J Etxabe","year":"1993","unstructured":"J. Etxabe, S. Gaztambide, P. Latorre, J.A. Vazquez, Acromegaly: an epidemiological study. J. Endocrinol. Invest. 16(3), 181\u2013187 (1993)","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"619_CR7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/cen.12020","volume":"78","author":"O Kwon","year":"2013","unstructured":"O. Kwon, Y.D. Song, S.Y. Kim, E.J. Lee, Nationwide survey of acromegaly in South Korea. Clin. Endocrinol. (Oxf.) 78(4), 577\u2013585 (2013). doi: 10.1111\/cen.12020","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"619_CR8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","volume":"151","author":"A Mestron","year":"2004","unstructured":"A. Mestron, S.M. Webb, R. Astorga, P. Benito, M. Catala, S. Gaztambide, J.M. Gomez, I. Halperin, T. Lucas-Morante, B. Moreno, G. Obiols, P. de Pablos, C. Paramo, A. Pico, E. Torres, C. Varela, J.A. Vazquez, J. Zamora, M. Albareda, M. Gilabert, Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur. J. Endocrinol. 151(4), 439\u2013446 (2004)","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"619_CR9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.endonu.2012.09.010","volume":"60","author":"G Sesmilo","year":"2013","unstructured":"G. Sesmilo, Epidemiology of acromegaly in Spain. Endocrinol. Nutr. 60(8), 470\u2013474 (2013). doi: 10.1016\/j.endonu.2012.09.010","journal-title":"Endocrinol. Nutr."},{"issue":"6","key":"619_CR10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1530\/eje.0.1340720","volume":"134","author":"I Yang","year":"1996","unstructured":"I. Yang, S. Park, M. Ryu, J. Woo, S. Kim, J. Kim, Y. Kim, Y. Choi, Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients. Eur. J. Endocrinol. 134(6), 720\u2013726 (1996)","journal-title":"Eur. J. Endocrinol."},{"issue":"13","key":"619_CR11","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1517\/14656566.9.13.2273","volume":"9","author":"L Katznelson","year":"2008","unstructured":"L. Katznelson, An update on treatment strategies for acromegaly. Expert Opin. Pharmacother. 9(13), 2273\u20132280 (2008). doi: 10.1517\/14656566.9.13.2273","journal-title":"Expert Opin. Pharmacother."},{"issue":"4","key":"619_CR12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrendo.2014.21","volume":"10","author":"A Giustina","year":"2014","unstructured":"A. Giustina, P. Chanson, D. Kleinberg, M.D. Bronstein, D.R. Clemmons, A. Klibanski, A.J. van der Lely, C.J. Strasburger, S.W. Lamberts, K.K. Ho, F.F. Casanueva, S. Melmed, Expert consensus document: a consensus on the medical treatment of acromegaly. Nat. Rev. Endocrinol. 10(4), 243\u2013248 (2014). doi: 10.1038\/nrendo.2014.21","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"619_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00002512-200017020-00001","volume":"17","author":"D Ferone","year":"2000","unstructured":"D. Ferone, A. Colao, A.J. van der Lely, S.W. Lamberts, Pharmacotherapy or surgery as primary treatment for acromegaly? Drugs Aging 17(2), 81\u201392 (2000)","journal-title":"Drugs Aging"},{"issue":"4","key":"619_CR14","doi-asserted-by":"crossref","first-page":"e61523","DOI":"10.1371\/journal.pone.0061523","volume":"8","author":"F Pita-Gutierrez","year":"2013","unstructured":"F. Pita-Gutierrez, S. Pertega-Diaz, S. Pita-Fernandez, L. Pena, G. Lugo, S. Sangiao-Alvarellos, F. Cordido, Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysis. PLoS One 8(4), e61523 (2013). doi: 10.1371\/journal.pone.0061523","journal-title":"PLoS One"},{"issue":"11","key":"619_CR15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jocn.2012.11.026","volume":"20","author":"PJ Wilson","year":"2013","unstructured":"P.J. Wilson, K.J. De-Loyde, J.R. Williams, R.I. Smee, Acromegaly: a single centre\u2019s experience of stereotactic radiosurgery and radiotherapy for growth hormone secreting pituitary tumours with the linear accelerator. J. Clin. Neurosci 20(11), 1506\u20131513 (2013). doi: 10.1016\/j.jocn.2012.11.026","journal-title":"J. Clin. Neurosci"},{"key":"619_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1871530314666140609110308","volume":"14","author":"E Espinosa","year":"2014","unstructured":"E. Espinosa, C. Ramirez, M. Mercado, The multimodal treatment of acromegaly: current status and future perspectives. Endocr. Metab. Immune. Disord. Drug Targets 14, 169 (2014)","journal-title":"Endocr. Metab. Immune. Disord. Drug Targets"},{"issue":"3","key":"619_CR17","doi-asserted-by":"crossref","first-page":"R223","DOI":"10.1530\/JME-14-0011","volume":"52","author":"D Cuevas-Ramos","year":"2014","unstructured":"D. Cuevas-Ramos, M. Fleseriu, Somatostatin receptor ligands and resistance to treatment in pituitary adenomas. J. Mol. Endocrinol. 52(3), R223\u2013240 (2014). doi: 10.1530\/JME-14-0011","journal-title":"J. Mol. Endocrinol."},{"issue":"9","key":"619_CR18","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1210\/jc.2011-0554","volume":"96","author":"JA Jane Jr","year":"2011","unstructured":"J.A. Jane Jr, R.M. Starke, M.A. Elzoghby, D.L. Reames, S.C. Payne, M.O. Thorner, J.C. Marshall, E.R. Laws Jr, M.L. Vance, Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J. Clin. Endocrinol. Metab. 96(9), 2732\u20132740 (2011). doi: 10.1210\/jc.2011-0554","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"619_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11102-013-0472-6","volume":"17","author":"I Fukuda","year":"2014","unstructured":"I. Fukuda, N. Hizuka, T. Muraoka, M. Kurimoto, Y. Yamakado, K. Takano, A. Ichihara, Clinical features and therapeutic outcomes of acromegaly during the recent 10\u00a0years in a single institution in Japan. Pituitary 17(1), 90\u201395 (2014). doi: 10.1007\/s11102-013-0472-6","journal-title":"Pituitary"},{"issue":"1","key":"619_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/EJE-12-0602","volume":"168","author":"C Schofl","year":"2013","unstructured":"C. Schofl, H. Franz, M. Grussendorf, J. Honegger, C. Jaursch-Hancke, B. Mayr, J. Schopohl, Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German acromegaly register. Eur. J. Endocrinol. 168(1), 39\u201347 (2013). doi: 10.1530\/EJE-12-0602","journal-title":"Eur. J. Endocrinol."},{"key":"619_CR21","author":"JJ Jacob","year":"2014","unstructured":"J.J. Jacob, J.S. Bevan, Should all patients with acromegaly receive somatostatin analogue therapy before surgery and if so, for how long? Clin. Endocrinol. (2014). doi: 10.1111\/cen.12553","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"619_CR22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF03345797","volume":"35","author":"D Ferone","year":"2012","unstructured":"D. Ferone, F. Gatto, F. Minuto, Pre-surgical treatment with somatostatin analogues in patients with acromegaly: the case for. J. Endocrinol. Invest. 35(6), 613\u2013615 (2012)","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"619_CR23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/BF03345798","volume":"35","author":"M Losa","year":"2012","unstructured":"M. Losa, V.G. Crippa, Pre-surgical treatment with somatostatin analogues in patients with acromegaly: the case against. J. Endocrinol. Invest. 35(6), 616\u2013618 (2012)","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"619_CR24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2265.2007.02878.x","volume":"67","author":"JC Maiza","year":"2007","unstructured":"J.C. Maiza, D. Vezzosi, M. Matta, F. Donadille, F. Loubes-Lacroix, M. Cournot, A. Bennet, P. Caron, Long-term (up to 18\u00a0years) effects on GH\/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa. Clin. Endocrinol. (Oxf.) 67(2), 282\u2013289 (2007). doi: 10.1111\/j.1365-2265.2007.02878.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"12","key":"619_CR25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1507\/endocrj.K10E-203","volume":"57","author":"M Shen","year":"2010","unstructured":"M. Shen, X. Shou, Y. Wang, Z. Zhang, J. Wu, Y. Mao, S. Li, Y. Zhao, Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study. Endocr. J. 57(12), 1035\u20131044 (2010)","journal-title":"Endocr. J."},{"key":"619_CR26","author":"L Zhang","year":"2014","unstructured":"L. Zhang, X. Wu, Y. Yan, J. Qian, Y. Lu, C. Luo, Preoperative somatostatin analogs treatment in acromegalic patients with macroadenomas. A meta-analysis. Brain Dev. (2014). doi: 10.1016\/j.braindev.2014.04.009","journal-title":"Brain Dev."},{"issue":"2","key":"619_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/EJE-14-0249","volume":"171","author":"SL Fougner","year":"2014","unstructured":"S.L. Fougner, J. Bollerslev, J. Svartberg, M. Oksnes, J. Cooper, S.M. Carlsen, Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial. Eur. J. Endocrinol. 171(2), 229\u2013235 (2014). doi: 10.1530\/EJE-14-0249","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"619_CR28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","volume":"16","author":"S Melmed","year":"2013","unstructured":"S. Melmed, F.F. Casanueva, A. Klibanski, M.D. Bronstein, P. Chanson, S.W. Lamberts, C.J. Strasburger, J.A. Wass, A. Giustina, A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3), 294\u2013302 (2013). doi: 10.1007\/s11102-012-0420-x","journal-title":"Pituitary"},{"issue":"2","key":"619_CR29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/er.2010-0002","volume":"32","author":"A Colao","year":"2011","unstructured":"A. Colao, R.S. Auriemma, G. Lombardi, R. Pivonello, Resistance to somatostatin analogs in acromegaly. Endocr. Rev. 32(2), 247\u2013271 (2011). doi: 10.1210\/er.2010-0002","journal-title":"Endocr. Rev."},{"issue":"1","key":"619_CR30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2265.2004.02064.x","volume":"61","author":"F Minuto","year":"2004","unstructured":"F. Minuto, E. Resmini, M. Boschetti, M. Arvigo, M.P. Sormani, M. Giusti, D. Ferone, A. Barreca, Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Clin. Endocrinol. (Oxf.) 61(1), 138\u2013144 (2004). doi: 10.1111\/j.1365-2265.2004.02064.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"619_CR31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1530\/EJE-13-0510","volume":"169","author":"P Ameri","year":"2013","unstructured":"P. Ameri, A. Giusti, M. Boschetti, M. Bovio, C. Teti, G. Leoncini, D. Ferone, G. Murialdo, F. Minuto, Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency. Eur. J. Endocrinol. 169(6), 767\u2013772 (2013). doi: 10.1530\/EJE-13-0510","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"619_CR32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1742-1241.2011.02682.x","volume":"65","author":"P Anagnostis","year":"2011","unstructured":"P. Anagnostis, Z.A. Efstathiadou, S.A. Polyzos, F. Adamidou, A. Slavakis, M. Sapranidis, I.D. Litsas, S. Katergari, D. Selalmatzidou, M. Kita, Acromegaly: presentation, morbidity and treatment outcomes at a single centre. Int. J. Clin. Pract. 65(8), 896\u2013902 (2011). doi: 10.1111\/j.1742-1241.2011.02682.x","journal-title":"Int. J. Clin. Pract."},{"issue":"8","key":"619_CR33","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1210\/jc.2013-1036","volume":"98","author":"RM Starke","year":"2013","unstructured":"R.M. Starke, D.M. Raper, S.C. Payne, M.L. Vance, E.H. Oldfield, J.A. Jane Jr, Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J. Clin. Endocrinol. Metab. 98(8), 3190\u20133198 (2013). doi: 10.1210\/jc.2013-1036","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"619_CR34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2265.2012.04492.x","volume":"78","author":"F Albarel","year":"2013","unstructured":"F. Albarel, F. Castinetti, I. Morange, B. Conte-Devolx, J. Gaudart, H. Dufour, T. Brue, Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients. Clin. Endocrinol. (Oxf.) 78(2), 263\u2013270 (2013). doi: 10.1111\/j.1365-2265.2012.04492.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"619_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13760-012-0128-8","volume":"113","author":"K Rompaey Van","year":"2013","unstructured":"K. Van Rompaey, D. Unuane, M. Moens, J. Duerinck, K. Poppe, B. Velkeniers, J. D\u2019Haens, Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center. Acta Neurol. Belg. 113(1), 49\u201354 (2013). doi: 10.1007\/s13760-012-0128-8","journal-title":"Acta Neurol. Belg."},{"issue":"5","key":"619_CR36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.surneu.2007.05.057","volume":"68","author":"A Santoro","year":"2007","unstructured":"A. Santoro, G. Minniti, A. Ruggeri, V. Esposito, M.L. Jaffrain-Rea, R. Delfini, Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results. Surg. Neurol. 68(5), 513\u2013518 (2007). doi: 10.1016\/j.surneu.2007.05.057","journal-title":"Surg. Neurol."},{"issue":"5","key":"619_CR37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3340\/jkns.2009.45.5.271","volume":"45","author":"MS Kim","year":"2009","unstructured":"M.S. Kim, H.D. Jang, O.L. Kim, Surgical results of growth hormone-secreting pituitary adenoma. J. Korean Neurosurg. Soc. 45(5), 271\u2013274 (2009). doi: 10.3340\/jkns.2009.45.5.271","journal-title":"J. Korean Neurosurg. Soc."},{"issue":"2","key":"619_CR38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11102-010-0273-0","volume":"14","author":"A Krzentowska-Korek","year":"2011","unstructured":"A. Krzentowska-Korek, F. Golkowski, A. Baldys-Waligorska, A. Hubalewska-Dydejczyk, Efficacy and complications of neurosurgical treatment of acromegaly. Pituitary 14(2), 157\u2013162 (2011). doi: 10.1007\/s11102-010-0273-0","journal-title":"Pituitary"},{"issue":"9","key":"619_CR39","doi-asserted-by":"crossref","first-page":"e73543","DOI":"10.1371\/journal.pone.0073543","volume":"8","author":"S Cheng","year":"2013","unstructured":"S. Cheng, R. Al-Agha, P.B. Araujo, O. Serri, L. Asa, S. Ezzat, Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly. PLoS One 8(9), e73543 (2013). doi: 10.1371\/journal.pone.0073543","journal-title":"PLoS One"},{"issue":"4","key":"619_CR40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/11599680-000000000-00000","volume":"32","author":"M Roset","year":"2012","unstructured":"M. Roset, S. Merino-Montero, M. Luque-Ramirez, S.M. Webb, P. Lopez-Mondejar, I. Salinas, A. Soto, C. Bernal, C. Villabona, D. De Luis, S. Donnay, H. Pascual, J. Perez-Luis, Spanish group of the, O.s.: Cost of clinical management of acromegaly in Spain. Clin. Drug Investig. 32(4), 235\u2013245 (2012). doi: 10.2165\/11599680-000000000-00000","journal-title":"Clin. Drug Investig."},{"issue":"4","key":"619_CR41","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/2010.7.FOCUS10167","volume":"29","author":"JA Gondim","year":"2010","unstructured":"J.A. Gondim, J.P. Almeida, L.A. de Albuquerque, E. Gomes, M. Schops, T. Ferraz, Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg. Focus 29(4), E7 (2010). doi: 10.3171\/2010.7.FOCUS10167","journal-title":"Neurosurg. Focus"},{"issue":"1","key":"619_CR42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000351512","volume":"36","author":"SH Kim","year":"2013","unstructured":"S.H. Kim, J.Y. Lee, H. Kim do, J.H. Ham, Y.K. Song, E.J. Lim, C.I. Park, S.J. Chang, S.S. Lee, Factors related to the initial stroke severity of posterior circulation ischemic stroke. Cerebrovasc Dis 36(1), 62\u201368 (2013). doi: 10.1159\/000351512","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"619_CR43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s007010050316","volume":"141","author":"RA Kristof","year":"1999","unstructured":"R.A. Kristof, B. Stoffel-Wagner, D. Klingmuller, J. Schramm, Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly? A randomized study. Acta Neurochir. (Wien) 141(4), 399\u2013405 (1999)","journal-title":"Acta Neurochir. (Wien)"},{"issue":"5","key":"619_CR44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00701-005-0511-9","volume":"147","author":"U Plockinger","year":"2005","unstructured":"U. Plockinger, H.J. Quabbe, Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study. Acta neurochir. 147(5), 485\u2013493 (2005). doi: 10.1007\/s00701-005-0511-9","journal-title":"Acta neurochir."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-015-0619-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0619-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:57:10Z","timestamp":1559440630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-015-0619-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,17]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1007\/s12020-015-0619-5","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,17]]}}}